Schott Pharma AG KGaA (CHIX:1SXPD) Ending Cash Position: €25 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CHIX:1SXPD Schott Pharma AG & CO KGaA CHIX:1SXPD
69 GF Score
Price €14.47
GF Value €18.05
! 4 Warning Signs
View Full Analysis

What is Schott Pharma AG KGaA Ending Cash Position?

Schott Pharma AG KGaA CHIX:1SXPD 69 Ending Cash Position is €25 Mil as of Jun. 2026. GuruFocus rates CHIX:1SXPD with a GF Score™ of 69/100 and a GF Value™ of €18.05. The stock has 4 warning signs investors should review.

Schott Pharma AG KGaA's Ending Cash Position for the quarter that ended in Jun. 2026 was €25 Mil.

Schott Pharma AG KGaA's quarterly Ending Cash Position increased from Dec. 2025 (€25 Mil) to Mar. 2026 (€28 Mil) but then declined from Mar. 2026 (€28 Mil) to Jun. 2026 (€25 Mil).

Schott Pharma AG KGaA's annual Ending Cash Position declined from Sep. 2023 (€24 Mil) to Sep. 2024 (€23 Mil) and declined from Sep. 2024 (€23 Mil) to Sep. 2025 (€22 Mil).

Schott Pharma AG KGaA Ending Cash Position Related Terms

Schott Pharma AG KGaA Ending Cash Position Historical Data

* Premium members only.

The historical data trend for Schott Pharma AG KGaA's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Schott Pharma AG KGaA Ending Cash Position Chart

Schott Pharma AG KGaA Annual Data
Trend Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Ending Cash Position
Get a 7-Day Free Trial 27.86 28.80 24.36 23.18 22.47

Schott Pharma AG KGaA Quarterly Data
Sep20 Sep21 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 28.29 22.47 24.59 27.81 24.88
CHIX:1SXPD
69GF Score
Schott Pharma AG & CO KGaA CHIX:1SXPD
Ending Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Schott Pharma AG KGaA Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Schott Pharma AG KGaA's Ending Cash Position for the fiscal year that ended in Sep. 2025 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=23.182+-0.71199999999999
=22

Schott Pharma AG KGaA's Ending Cash Position for the quarter that ended in Jun. 2026 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=27.813+-2.936
=25

Frequently Asked Questions Learn more about Ending Cash Position →
What does a Ending Cash Position of €25 Mil mean?
Schott Pharma AG KGaA (CHIX:1SXPD) has a Ending Cash Position of €25 Mil as of Jun. 2026. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Schott Pharma AG KGaA and its competitors.
Is Schott Pharma AG KGaA's Ending Cash Position too high?
Schott Pharma AG KGaA's current Ending Cash Position is €25 Mil. Overall, Schott Pharma AG KGaA has a GF Score™ of 69/100, reflecting its overall financial health beyond just this single metric.
How does Schott Pharma AG KGaA's Ending Cash Position compare to ISRG and BDX?
Schott Pharma AG KGaA's Ending Cash Position of €25 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Ending Cash Position for a Medical Devices & Instruments company?
A good Ending Cash Position depends on the Medical Devices & Instruments industry context. However, Ending Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Ending Cash Position mean?
A high Ending Cash Position can signal that a stock is expensive relative to its fundamentals. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Schott Pharma AG KGaA and its competitors. Schott Pharma AG KGaA's current Ending Cash Position is €25 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Schott Pharma AG KGaA stock overvalued right now?
Schott Pharma AG KGaA (CHIX:1SXPD) has a current Ending Cash Position of €25 Mil. The stock's GF Value™ is €18.05, compared to a current price of €14.47 — trading 19.8% below its estimated fair value. The current Ending Cash Position is €25 Mil. Schott Pharma AG KGaA's overall GF Score™ is 69/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Ending Cash Position calculated?
Ending Cash Position is calculated from a company's financial statements. For Schott Pharma AG KGaA (CHIX:1SXPD), the current Ending Cash Position is €25 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Schott Pharma AG KGaA (CHIX:1SXPD) Overvalued in 2026?

Based on GuruFocus' analysis, Schott Pharma AG KGaA stock appears to be undervalued. The current stock price of €14.47 is trading 19.8% below its estimated GF Value™ of €18.05.

Key valuation signals for CHIX:1SXPD:

  • Ending Cash Position: €25 Mil
  • GF Value™: €18.05 vs. price of €14.47 (19.8% below fair value)
  • GF Score™: 69/100 with 4 warning signs

No single metric tells the full story. See the CHIX:1SXPD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Schott Pharma AG KGaA Business Description

Address Hattenbergstrasse 10, Mainz, RP, DEU, 55122
Schott Pharma AG & CO KGaA is an international provider of drug containment solutions and delivery systems for injectable drugs for pharma, biotech and life-sciences. Its business operates in two segments: Drug Containment Solutions (DCS) and Drug Delivery Systems (DDS). The majority of revenue is being generated from the DCS segment, which includes products like vials, cartridges, and ampoules, and provides customers with sterile and non-sterile options in standard and high-end formats for drug storage. Geographically, the company generates revenue from Europe, the Middle East, Africa (EMEA), Asia and the South Pacific, North America, and South America.
69GF Score

Get the complete analysis for CHIX:1SXPD

Ending Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€14.47
Price
€18.05
GF Value